T H 2 and T H 17 inflammatory pathways are reciprocally regulated in asthma
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Increasing evidence suggests that asthma is a heterogeneous disorder regulated by distinct molecular mechanisms. In a cross-sectional study of asthmatics of varying severity (n = 51), endobronchial tissue gene expression analysis revealed three major patient clusters: TH2-high, TH17-high, and TH2/17-low. TH2-high and TH17-high patterns were mutually exclusive in individual patient samples, and their gene signatures were inversely correlated and differentially regulated by interleukin-13 (IL-13) and IL-17A. To understand this dichotomous pattern of T helper 2 (TH2) and TH17 signatures, we investigated the potential of type 2 cytokine suppression in promoting TH17 responses in a preclinical model of allergen-induced asthma. Neutralization of IL-4 and/or IL-13 resulted in increased TH17 cells and neutrophilic inflammation in the lung. However, neutralization of IL-13 and IL-17 protected mice from eosinophilia, mucus hyperplasia, and airway hyperreactivity and abolished the neutrophilic inflammation, suggesting that combination therapies targeting both pathways may maximize therapeutic efficacy across a patient population comprising both TH2 and TH17 endotypes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The data summarized above suggest that targeting JAK and STAT3 with small-molecule inhibitors may provide a superior anti-asthma treatment approach compared with standard therapies as, they would target both Th2- and Th17-associated asthmas (Choy et al., 2015).”
From Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution (2020) · cites this paper as Choy et al., 2015
In the citing paper
“almost all murine models of intestinal fibrosis are influenced by the microbiota154”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [154]
Citations
Cites
The global burden of asthma: executive summary of the GINA Dissemination Committee Report
Masoli, M., Fabian, D., Holt, S., Beasley, R., & Program, G. I. F. A. (. (2004) · Allergy · doi:10.1111/j.1398-9995.2004.00526.x · Cited by 3,529
Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program
Moore, W. C., Meyers, D. A., Wenzel, S. E., Teague, W. G., Li, H., Li, X., D'Agostino, R., Castro, M., Curran-Everett, D., Fitzpatrick, A. M., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0896oc · Cited by 2,129
British Guideline on the Management of Asthma
British Thoracic Society Scottish Intercollegiate Guidelines Network (2008) · Thorax · doi:10.1136/thx.2008.097741 · Cited by 2,021
Cluster analysis and clinical asthma phenotypes
Haldar, P., Pavord, I. D., Shaw, D. E., Berry, M. A., Thomas, M., Brightling, C. E., Wardlaw, A. J., & Green, R. H. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200711-1754oc · Cited by 1,987
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
Haldar, P., Brightling, C. E., Hargadon, B., Gupta, S., Monteiro, W., Sousa, A., Marshall, R. P., Bradding, P., Green, R. H., Wardlaw, A. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808991 · Cited by 1,871 · cited 1×
“Identifying the molecular mechanisms driving subtypes of asthma has the potential to reveal drug targets, biomarkers to predict treatment response, and appropriately target therapy, as evidenced by recent clinical studies of T helper 2 (TH2) cytokine antagonists (8, 9).”
BackgroundSelf-citationThe development of allergic inflammation
Galli, S. J., Tsai, M., & Piliponsky, A. M. (2008) · Nature · doi:10.1038/nature07204 · Cited by 1,839
T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma
Woodruff, P. G., Modrek, B., Choy, D. F., Jia, G., Abbas, A. R., Ellwanger, A., Arron, J. R., Koth, L. L., & Fahy, J. V. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0392oc · Cited by 1,803 · cited 6×
“SERPINB2, CLCA1, and POSTN were used as IL-13–responsive TH2 signature genes as described previously (25, 26).”
BackgroundMethodInfluentialSelf-citationAsthma exacerbations and sputum eosinophil counts: a randomised controlled trial
Green, R. H., Brightling, C. E., McKenna, S., Hargadon, B., Parker, D., Bradding, P., Wardlaw, A. J., & Pavord, I. D. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11679-5 · Cited by 1,755
Self-citationLebrikizumab Treatment in Adults with Asthma
Corren, J., Lemanske, R. F., Hanania, N. A., Korenblat, P. E., Parsey, M. V., Arron, J. R., Harris, J. M., Scheerens, H., Wu, L. C., Su, Z., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106469 · Cited by 1,514
Self-citationTargeting IL-17 and TH17 cells in chronic inflammation
Miossec, P., & Kolls, J. K. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3794 · Cited by 1,414
Cited by
Items 201–300 of 458
Mleczko, M., Gerkowicz, A., & Krasowska, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031767 · Cited by 31
Therapeutic Potential of Combining IL-6 and TNF Blockade in a Mouse Model of Allergic Asthma
Namakanova, O. A., Gorshkova, E. A., Zvartsev, R. V., Nedospasov, S. A., Drutskaya, M. S., & Gubernatorova, E. O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073521 · Cited by 37
“Moreover, the predominant type of T-helper cells may predict the severity of asthma: while asthma of moderate severity is characterized by Th2-cell activation, severe asthma is usually dependent on Th17/Th1-cell responses in the airways with subsequent neutrophilic infiltration [72].”
BackgroundAx, E., Jevnikar, Z., Cvjetkovic, A., Malmhäll, C., Olsson, H., Rådinger, M., & Lässer, C. (2020) · Respiratory Research · doi:10.1186/s12931-020-01402-3 · Cited by 32
Substance P‐induced lung inflammation in mice is mast cell dependent
Wang, N., Wang, J., Zhang, Y., Hu, S., Zhang, T., Wu, Y., Sun, X., Zhang, T., Yang, S., & He, L. (2021) · Clinical & Experimental Allergy · doi:10.1111/cea.13902 · Cited by 31
Müller, S., Welchowski, T., Schmid, M. C., Maintz, L., Herrmann, N., Wilsmann‐Theis, D., Royeck, T., Havenith, R., & Bieber, T. R. M. (2023) · Allergy · doi:10.1111/all.15921 · Cited by 33
Asthma Phenotypes and Biomarkers
Grunwell, J. R., & Fitzpatrick, A. M. (2025) · Respiratory Care · doi:10.1089/respcare.12352 · Cited by 31
“163 166 Patients with obesity-related asthma with high plasma IL-6 levels may also have increased blood neutrophils and plasma C-reactive protein along with reduced lung function and increased exacerbation frequency compared to patients with obesity-related asthma and low IL-6.”
Wu, B., Zhang, S., Guo, Z., Wang, G., Zhang, G., Xie, L., Lou, J., Chen, X., Wu, D., Bergmeier, W., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.09.004 · Cited by 29
“Conversely, pathogenic Th17 and Th2 cell generation appears reciprocal (Choy et al., 2015; Harrington et al., 2005).”
Immune biomarkers in the spectrum of childhood noncommunicable diseases
Skevaki, C. L., van den Berg, J., Jones, N., Garssen, J., Vuillermin, P., Levin, M. E., LANDAY, A. L., Renz, H. E., Calder, P. C., & Thornton, C. A. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.03.012 · Cited by 29
Microbiota, regulatory T cell subsets, and allergic disorders
Ohnmacht, C. (2016) · Allergo Journal International · doi:10.1007/s40629-016-0118-0 · Cited by 30
“Indeed, one study recently highlighted a possible 2 and 17 counter regulation in the case of allergic asthma [72].”
BackgroundElaidy, S. M., Essawy, S. S., Hussain, M. A., El-Kherbetawy, M. K., & Hamed, E. (2017) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-017-1459-z · Cited by 29
Endotypes of difficult-to-control asthma in inner-city African American children
Brown, K. R., Krouse, R. Z., Calatroni, A., Visness, C. M., Sivaprasad, U., Kercsmar, C. M., Matsui, E. C., West, J. B., Makhija, M., Gill, M. A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180778 · Cited by 29
“Targeting both TH2 and TH17 associated pathways of inflammation has been suggested previously given the concern that isolated targeting of TH2 cytokines may promote TH17-associated corticosteroid resistant neutrophilic airway inflammation[45, 46].”
BackgroundThe Role of Exposomes in the Pathophysiology of Autoimmune Diseases II: Pathogens
Vojdani, A., Vojdani, E., Rosenberg, A. Z., & Shoenfeld, Y. (2022) · Pathophysiology · doi:10.3390/pathophysiology29020020 · Cited by 32
“Conversely, low Tregs with elevated Th2 and Th17 is the most pathogenic combination for allergies and asthma [108,109].”
BackgroundFord, M. L., Reza, M. I., Ruwanpathirana, A., Sathish, V., & Britt, R. D. (2025) · Immunological Reviews · doi:10.1111/imr.70007 · Cited by 29
Immune responses and exacerbations in severe asthma
Camiolo, M. J., Kale, S. L., Oriss, T. B., Gauthier, M. C., & Ray, A. (2021) · Current Opinion in Immunology · doi:10.1016/j.coi.2021.03.004 · Cited by 27
Lamb, D. J., Sousa, D. D., Quast, K., Fundel‐Clemens, K., Erjefalt, J. S., Sandén, C., Hoffmann, H. J., Kästle, M., Schmid, R., Menden, K., et al. (2021) · Respiratory Research · doi:10.1186/s12931-021-01743-7 · Cited by 28
“Primary human bronchial smooth muscle cells were also stimulated with IL-17A or IL-22 for 24 h and increases in IL-6, IL-8 and CXCL1 (Fig.”
MethodResultInfluentialBiomarkers and asthma management: analysis and potential applications
Richards, L. B., Neerincx, A. H., van Bragt, J. J. M. H., Sterk, P. J., Bel, E. H., & der Zee, A. H. M. (2018) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000426 · Cited by 29
Update on the role of endoplasmic reticulum stress in asthma.
Miao, K., Zhang, L., Pan, T. S., & Wang, Y. (2020) · American Journal of Translational Research · Cited by 33
Diagnostic and Therapeutic Value of Hsa_circ_0002594 for T Helper 2-Mediated Allergic Asthma
Huang, Z., Fu, B., Qi, X., Xu, Y., Mou, Y., Zhou, M., Cao, Y., Wu, G., Xie, J., Zhao, J., et al. (2020) · International Archives of Allergy and Immunology · doi:10.1159/000511612 · Cited by 27
Wang, Y., Noyer, L., Kahlfuß, S., Raphael, D., Tao, A. Y., Kaufmann, U., Zhu, J., Mitchell-Flack, M., Sidhu, I., Zhou, F., et al. (2022) · Science Advances · doi:10.1126/sciadv.abn6552 · Cited by 29
Ramelli, S. C., Comer, B. S., McLendon, J. M., Sandy, L. L., Ferretti, A. P., Barrington, R. A., Sparks, J., Matar, M. M., Fewell, J. G., & Gerthoffer, W. T. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.12.033 · Cited by 25
“Biomarker studies have revealed sets of lung transcripts and proteins associated with asthma.(23,24) Many of the same genes upregulated in asthma are also upregulated in a short-term HDMmodel of asthma.”
BackgroundLi, L., Fang, Z., Lee, Y. K., Zhao, J., Zhang, H., Lu, W., & Chen, W. (2020) · Food & Function · doi:10.1039/d0fo01363c · Cited by 27
Shi, T., Li, N., He, Y., Feng, J., Mei, Z., Du, Y., & Jie, Z. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104867 · Cited by 24
Shi, B., Hao, Y., Li, W., Dong, H., Xu, M., & Gao, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.883885 · Cited by 24
“However, in contrast to EA patients, some patients with NA exhibit neutrophil dominance airway inflammation that can be driven by M1 macrophages or Th1/Th17 lymphocytes (3, 10, 11).”
BackgroundDynamics of helper CD4 T cells during acute and stable allergic asthma
Lu, Y., Kared, H., Tan, S. W., Becht, É., Newell, E. W., Bever, H. P. S. V., Ng, T. P., & Larbi, A. (2018) · Mucosal Immunology · doi:10.1038/s41385-018-0057-9 · Cited by 26
Yang, C., Tian, J., Ko, W., Shih, C., & Chiou, Y. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6939 · Cited by 26
“Th17 cells and the cytokines produced by Th17 cells increase airway inflammation through neutrophil and eosinophil activation (30-33).”
BackgroundSevere refractory asthma: current treatment options and ongoing research
Menzella, F., Bertolini, F., Biava, M., Galeone, C., Scelfo, C., & Caminati, M. (2018) · Drugs in Context · doi:10.7573/dic.212561 · Cited by 25
The emergence of new biologics for severe asthma
Eger, K. A. B., & Bel, E. H. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.05.005 · Cited by 23
30 Years of Biotherapeutics Development—What Have We Learned?
Ghilardi, N., Pappu, R., Arron, J. R., & Chan, A. C. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101619-031510 · Cited by 27
Self-citationBiologic Therapy in Severe Asthma: A Phenotype-Driven and Targeted Approach
D’Amato, M., Pastore, D., Lupia, C., Candia, C., Bruni, A., Garofalo, E., Longhini, F., Maglio, A., Petrone, A., Vatrella, A., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14134749 · Cited by 27
Thompson, E. E., Dang, Q. N., Mitchell-Handley, B., Rajendran, K., Ram‐Mohan, S., Solway, J., Ober, C., & Krishnan, R. (2020) · Genome Medicine · doi:10.1186/s13073-020-00759-w · Cited by 36
Sánchez‐Ovando, S., Simpson, J. L., Barker, D., Baines, K. J., & Wark, P. A. B. (2021) · Clinical & Experimental Allergy · doi:10.1111/cea.13986 · Cited by 24
Sciurba, J. C., Gieseck, R. L., Jiwrajka, N., White, S. D., Karmele, E. P., Redes, J., Vannella, K. M., Henderson, N. C., Wynn, T. A., & Hart, K. M. (2019) · The Journal of Pathology · doi:10.1002/path.5215 · Cited by 22
“We observed the same trend of decreased type 17 inflammation in Pdgfrb-cre+ animals as seen in previous experiments (Figure 4), with anti-IL-13 antibody treatment having minimal effect on the type 17 signature as assessed by total tissue Il17a expression, frequency of IL-17A-producing CD4+ T-cells in the lung, total t…”
BackgroundInfluentialSelf-citationILC2 Diversity, Location, and Function in Pulmonary Disease
Verma, M., Can, U. I., & Reinhardt, R. L. (2025) · Immunological Reviews · doi:10.1111/imr.70036 · Cited by 24
Wang, Y., Sui, Y., Yao, J., Jiang, H., Tian, Q., Tang, Y., Ou, Y., Tang, J. P., & Tan, N. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae362 · Cited by 27
“Concurrently, bronchial epithelial cells, upon exposure to environmental stimuli, release cytokines such as IL-25, IL-33, and thymic stromal lymphopoietin (TSLP), which further stimulate Th17 cell proliferation and IL-17 release, exacerbating lung inflammation [54, 55].”
BackgroundMgl2+ cDC2s coordinate fungal allergic airway type 2, but not type 17, inflammation in mice
Cook, P. C., Brown, S. L., Houlder, E. L., Furlong-Silva, J., Conn, D. P., Colombo, S. A. P., Baker, S. M., Svedberg, F. R., Howell, G. J., Bertuzzi, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55663-3 · Cited by 26
Correlation of PD-1/PD-L1 Signaling Pathway with Treg/Th17 Imbalance from Asthmatic Children
Xia, X., Liu, J., & Guo, J.-Y. (2018) · International Archives of Allergy and Immunology · doi:10.1159/000489338 · Cited by 22
Church, J. S., Tamayo, J. M., Ashwood, P., & Schwartzer, J. J. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.12.014 · Cited by 23
Jaeger, N., McDonough, R. T., Rosen, A. L., Hernandez-Leyva, A. J., Wilson, N. G., Lint, M. A., Russler-Germain, E. V., Chai, J. N., Bacharier, L. B., Hsieh, C., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108331 · Cited by 23
“In contrast, other studies suggest that IL-17Amay directly antagonize Th2 responses and reduce AAI (Barlow et al., 2011; Choy et al., 2015; Newcomb et al., 2013; Schnyder-Candrian et al., 2006).”
Diver, S. E., Sridhar, S., Khalfaoui, L., RUSSELL, R. J., Emson, C. L., Griffiths, J. M., Reyes, M. D. L., Yin, D., Colice, G., & Brightling, C. E. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.04.024 · Cited by 21
Wu, D., Zhang, X. Y., Zimmerly, K. M., Wang, R., Wang, C., Hunter, R., Wu, X. Y., Campen, M. J., Liu, M., & Yang, X. O. (2023) · Mucosal Immunology · doi:10.1016/j.mucimm.2023.05.007 · Cited by 21
Xu, C., Zhang, T., Wang, H., Zhu, L., Ruan, Y., Huang, Z., Wang, J., Zhu, H., Huang, C., & Pan, M. (2023) · Journal of Autoimmunity · doi:10.1016/j.jaut.2023.103128 · Cited by 21
New perspectives on the regulation of type II inflammation in asthma
Becerra-Díaz, M., Wills-Karp, M. A., & Heller, N. M. (2017) · F1000Research · doi:10.12688/f1000research.11198.1 · Cited by 24
Immunologie der Polyposis nasi als Grundlage für eine Therapie mit Biologicals
Klimek, L., Koennecke, M., Hagemann, J., Wollenberg, B., & Becker, S. (2018) · HNO · doi:10.1007/s00106-018-0557-7 · Cited by 21
Galili, E., Barzilai, A., Twig, G., Caspi, T., Daniely, D., Shreberk‐Hassidim, R., & Astman, N. (2020) · Acta Dermato Venereologica · doi:10.2340/00015555-3485 · Cited by 21
Li, L., Fang, Z., Liu, Z., Zhao, J., Zhang, H., Wang, S., He, J., Lu, W., & Chen, W. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104286 · Cited by 22
Patient stratification and the unmet need in asthma
Swedin, L., Saarne, T., Rehnberg, M., Glader, P., Niedzielska, M., Johansson, G., Hazon, P., & Catley, M. C. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.06.016 · Cited by 20
“In another recent study, a Th17 asthma phenotype was associated with a high eosinophil count, both in blood and bronchial biopsies (Choy et al., 2015).”
BackgroundJakieła, B., Soja, J., Sładek, K., Przybyszowski, M., Plutecka, H., Gielicz, A., Lichołai, S., Aab, A., Rebane, A., & Bochenek, G. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.10.029 · Cited by 21
Altieri, A., Piyadasa, H., Hemshekhar, M., Osawa, N., Recksiedler, B., Spicer, V., Hiemstra, P. S., Halayko, A. J., & Mookherjee, N. (2022) · Journal of Inflammation · doi:10.1186/s12950-022-00323-w · Cited by 24
Omics approaches in asthma research: Challenges and opportunities
Yue, M., Tao, S., Gaietto, K. M., & Chen, W. (2024) · Chinese Medical Journal - Pulmonary and Critical Care Medicine · doi:10.1016/j.pccm.2024.02.002 · Cited by 22
Morales-Primo, A. U., Becker, I., Zamora, C., & Zamora‐Chimal, J. (2024) · Immune Network · doi:10.4110/in.2024.24.e14 · Cited by 24
“Blockade of Th2 cytokines, IL-4 and IL-13 in an asthma mice model led increased production of IL-17A (127).”
BackgroundInfluentialOutstanding animal studies in allergy I. From asthma to food allergy and anaphylaxis
Jensen‐Jarolim, E., Pali‐Schöll, I., & Roth‐Walter, F. (2017) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000363 · Cited by 20
Wang, Z., Ji, N., Chen, Z., Sun, Z., Wu, C., Yu, W., Hu, F., Huang, M., & Zhang, M. (2020) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2020.12.5.859 · Cited by 20
Kim, D., McAlees, J. W., Bischoff, L. J., Kaur, D., Houshel, L., Gray, J. K., Hargis, J. M., Davis, X. D., Dudas, P. L., Deshmukh, H. S., et al. (2018) · Clinical & Experimental Allergy · doi:10.1111/cea.13301 · Cited by 21
“For example, while blockade of IL‐13 in mouse models has been ascribed a powerful inhibitory role on the development of allergic asthma,(37-39) recent evidence suggests an antagonistic relationship between Th2 cytokines and Th17 cells.(40-43) As such, inhibition of IL‐13 in mixed Th2/ Th17 mouse models of asthma drove…”
BackgroundResultInfluentialUnravelling the complexity of tissue inflammation in uncontrolled and severe asthma
Erjefalt, J. S. (2018) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000536 · Cited by 20
Th2/Th17 reciprocal regulation: twists and turns in the complexity of asthma phenotypes
Lynch, J. P., Ferreira, M. A. R., & Phipps, S. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.10.69 · Cited by 20
“seek to address this latter issue by exploring the reciprocal regulatory processes between Th2 and Th17 immunity in asthma (7).”
BackgroundThe emerging role of IL-23 in asthma and its clinical implications
Wu, A. Y., & Peebles, R. S. (2022) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2023.2125380 · Cited by 20
Airway gene expression identifies subtypes of type 2 inflammation in severe asthma
Frøssing, L., Silberbrandt, A. W., von Bülow, A., Klein, D. K., Christensen, M. R., Backer, V., Baines, K. J., & Porsbjerg, C. M. (2021) · Clinical & Experimental Allergy · doi:10.1111/cea.13966 · Cited by 19
Treatment approaches for the patient with T2 low asthma
Carr, T. F. (2021) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2021.05.027 · Cited by 19
The Emerging Roles of T Helper Cell Subsets and Cytokines in Severe Neutrophilic Asthma
Chen, Q., Nian, S., Ye, Y., Liu, D., Yu, H. Z., Xiong, H., Pan, B., Lu, X. J., Fan, C., & Yuan, Q. (2021) · Inflammation · doi:10.1007/s10753-021-01598-6 · Cited by 20
“Based on neutrophil and eosinophil counts in sputum or blood [32, 33], severe asthma patients are classified with NA or EA.”
BackgroundGenomic characterization and therapeutic utilization of IL-13-responsive sequences in asthma
Koh, K. D., Bonser, L. R., Eckalbar, W. L., Barnea, O. Y., Shen, J. J., Zeng, X., Hargett, K. L., Sun, D. I., Zlock, L. T., Finkbeiner, W. E., et al. (2022) · Cell Genomics · doi:10.1016/j.xgen.2022.100229 · Cited by 25
“Because of the biological constraints involved in growing HBECs, which provide only a limited number of cells and passages, we limited the amount of candidate cisregulatory sequences (CRSs) tested in our MPRA using the following criteria (Figure 3B): (1) IL-13-responsive peaks in our H3K27ac ChIP-seq data that contain…”
IL‐1β promotes IL‐17A production of ILC3s to aggravate neutrophilic airway inflammation in mice
Yang, D., Li, Y., Liu, T., Yang, L., He, L., Huang, T., Zhang, L., Luo, J. F., & Liu, C. (2023) · Immunology · doi:10.1111/imm.13644 · Cited by 22
“IL-17 is also related to airway hyperresponsiveness [82], airway remodelling [81], and hormone resistance [74, 83].”
Yin, M., Wadhwa, R., Marshall, J. E., Gillis, C. M., Kim, R., Dua, K., Pålsson‐McDermott, E. M., Fallon, P. G., Hansbro, P. M., & O'Neill, L. A. J. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300155 · Cited by 21
Secretory IgA in breast milk protects against asthma through modulation of the gut microbiota
Donald, K., Serapio-Palacios, A., Gerbec, Z. J., Bozorgmehr, T., Holani, R., Cruz, A. R., Schnupf, P., & Finlay, B. B. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114835 · Cited by 20
Immune status for monitoring and treatment of bladder cancer
Pan, S., Li, S., Zhan, Y., Chen, X., Sun, M., Liu, X., Wu, B., Li, Z., & Liu, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.963877 · Cited by 19
Quantum dots and mouse strain influence house dust mite-induced allergic airway disease
Scoville, D., Nolin, J. D., Ogden, H. L., An, D., Afsharinejad, Z., Johnson, B. W., Bammler, T. K., Gao, X., Frevert, C. W., Altemeier, W. A., et al. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.01.018 · Cited by 19
“Neutrophils, which can be recruited by IL-17 via CXCL1/KC induction, are also elevated in some subtypes of asthma (Choy et al., 2015; Lambrecht and Hammad, 2015).”
BackgroundPhysiopathology of Allergic Asthma: A Comprehensive Review
Ghrairi, N., & Elhechmi, Y. Z. (2025) · Scandinavian Journal of Immunology · doi:10.1111/sji.70032 · Cited by 21
γδT17/γδTreg cell subsets: a new paradigm for asthma treatment
Yao, Y., Qin, C., Yang, C., & Huang, T.-X. (2021) · Journal of Asthma · doi:10.1080/02770903.2021.1980585 · Cited by 18
“Another study has shown that IL-17 may be a target factor for gene-targeted therapy of hormone-resistant asthma (116).”
BackgroundAging-Related Mechanisms Contribute to Corticosteroid Insensitivity in Elderly Asthma
Ford, M. L., Ruwanpathirana, A., Lewis, B. W., & Britt, R. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076347 · Cited by 20
“These inflammatory endotypes in asthma are associated with corticosteroid insensitivity, poor symptom control, and greater asthma severity [10,11].”
BackgroundSage, S. E., Leeb, T., Jagannathan, V., & Gerber, V. (2023) · Immunology · doi:10.1111/imm.13745 · Cited by 20
“associated gene expression appears to be regulated in opposite direction in the airways of human 531 patients (98).”
BackgroundChinn, A. M., & Insel, P. A. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15095 · Cited by 22
Biological treatments for severe asthma
Jin, H. J. (2020) · Journal of Yeungnam Medical Science · doi:10.12701/yujm.2020.00647 · Cited by 19
Unique Allergic Asthma Phenotypes in Offspring of House Dust Mite–exposed Mice
Lebold, K. M., Drake, M. G., Pincus, A. B., Pierce, A. B., Fryer, A. D., & Jacoby, D. B. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2021-0535oc · Cited by 19
Introduction to “allergic inflammation”
Nakayama, T. (2017) · Immunological Reviews · doi:10.1111/imr.12566 · Cited by 18
Pyo, J. J., Ahn, S., Jin, S. H., An, S., Lee, E., Choi, J., Shin, J. C., Choi, H., Kim, H.-J., Choi, D., et al. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02506-6 · Cited by 20
The effects of inhaled corticosteroids on healthy airways
Marchi, E., Hinks, T., Richardson, M., Khalfaoui, L., Symon, F. A., Rajasekar, P., Clifford, R. L., Hargadon, B., Austin, C. D., MacIsaac, J. L., et al. (2024) · Allergy · doi:10.1111/all.16146 · Cited by 19
“8,9 Approximately 50–80% of people with steroid-naive ‘mild’ asthma demonstrate evidence of blood or airway eosinophilia, with a concomitant increase in the fraction of exhaled nitric oxide (FeNO).”
InfluentialSelf-citationMuñoz, X., Álvarez-Puebla, M. J., Arismendi, E., Arochena, L., Ausín, P., Barranco, P., Bobolea, I. D., Cañas, J. A., Cárdaba, B., Lessmann, A. C., et al. (2018) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2017.12.012 · Cited by 21
Chen, J., Li, C., Hongxian, L. I., Yu, H., Zhang, X., Yan, M., Guo, Y., & Yao, Z. (2020) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16563 · Cited by 17
Xue, L., Li, C., Ge, G., Zhang, S., Tian, L., Wang, Y., Zhang, H., Ma, Z., & Lu, Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.703724 · Cited by 17
“Many previous studies have indicated that T helper 2 (Th2) cells play a crucial role in the progression of the asthma disease process (Wills-Karp et al., 1998; Kips et al., 2001; Choy et al., 2015).”
ResultLayman, A. A. K., Sprout, S. L., Phillips, D., & Oliver, P. M. (2017) · Scientific Reports · doi:10.1038/srep39649 · Cited by 19
Wang, P., Su, H., Zhang, L., Chen, H., Hu, X., Yang, F., Lv, J., Zhang, L., & Zhao, Y. X. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.06.026 · Cited by 17
Zhang, F., Su, X., Huang, G., Xin, X., Cao, E.-H., Shi, Y. P., & Song, Y. (2017) · Journal of Immunology Research · doi:10.1155/2017/5358647 · Cited by 17
Jang, E., Nguyen, Q. T., Kim, S., Kim, D., Le, T. H. N., Keslar, K. S., Dvorina, N., Aronica, M. A., & Min, B. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700211 · Cited by 16
“eosinophils, are the dominant inflammatory leukocytes infiltrating the lung tissues (4, 5), and Th17-mediated neutrophilic asthma is associated with a severe persistent form (6, 7).”
BackgroundAsthma and psoriasis: What do they have in common? IL-17A!
Busse, W. W. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.09.006 · Cited by 16
Effect of IL‑7 on Th17 cell responses in a mouse model of neutrophilic asthma
Zhang, X., Zhang, M., Jiang, M., & Nong, G. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11191 · Cited by 15
“…and iii) high number of neutrophils in BALF. accumulating evidence suggests that Th17 cells are involved in the pathogenesis of asthma (9,12), including severe forms of asthma that are refractory to treatment with cortico-steroids (13). il-17 production by Th17 cells is associated with…”
Initiation of type 2 immunity at barrier surfaces
McDaniel, M. M., Lara, H. I., & von Moltke, J. (2023) · Mucosal Immunology · doi:10.1016/j.mucimm.2022.11.002 · Cited by 15
Type-2-low severe asthma endotypes for new treatments: the new asthma frontier
Chung, K. F. (2023) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000899 · Cited by 16
Ma, Y., Li, L., Hu, Y., Han, S., Yang, Q., Pu, W., Zhang, J., & Zhang, J. (2023) · Nano Today · doi:10.1016/j.nantod.2023.101957 · Cited by 16
Reyes, J. L., Vannan, D. T., Vo, T., Gulamhusein, A. F., Beck, P. L., Reimer, R. A., & Eksteen, B. (2018) · Scientific Reports · doi:10.1038/s41598-018-21112-7 · Cited by 15
Thornell, I. M., Rehman, T., Pezzulo, A. A., & Welsh, M. J. (2020) · The Journal of Physiology · doi:10.1113/jp280120 · Cited by 15
Shi, T., He, Y., Sun, W., Wu, Y., Li, L., Jie, Z., & Su, X. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.05.017 · Cited by 15
“Administration of IL-17 as well as transfer of Th17 cells worsened AHR and airway allergic inflammation, whereas neutralization of IL-17 attenuated AHR and airway eosinophilia (Choy et al., 2015; Kawakami et al., 2012).”
BackgroundCandida gut commensalism and inflammatory disease
Gu, Z.-Q., Tseng, K.-Y., & Tsai, Y.-H. (2020) · Medicine in Microecology · doi:10.1016/j.medmic.2020.100008 · Cited by 15
Association of Asthma With Treatments and Outcomes in Children With Critical Influenza
Maddux, A. B., Grunwell, J. R., Newhams, M. M., Chen, S., Olson, S. M., Halasa, N., Weiss, S. L., Coates, B. M., Schuster, J. E., Hall, M. W., et al. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.10.045 · Cited by 14
dos Santos, T. M., Righetti, R. F., Rezende, B. G., de Campos, E. C., Camargo, L. D. N., Saraiva-Romanholo, B. M., Fukuzaki, S., Prado, C. M., Leick, E. A., Martins, M. A., et al. (2020) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753466620962665 · Cited by 16
Oiwa, T., Honda, T., Otsuka, A., & Kabashima, K. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14622 · Cited by 13
Quantum dot induced acute changes in lung mechanics are mouse strain dependent
Scoville, D., White, C. C., Botta, D., An, D., Afsharinejad, Z., Bammler, T. K., Gao, X., Altemeier, W. A., & Kavanagh, T. J. (2018) · Inhalation Toxicology · doi:10.1080/08958378.2018.1542046 · Cited by 13
“We also measured IL-17, which has been associated with neutrophil recruitment (Choy et al., 2015).”
Khumalo, J., Kirstein, F., Scibiorek, M., Hadebe, S., & Brombacher, F. (2019) · Allergy · doi:10.1111/all.14137 · Cited by 16
Beyond type 2 cytokines in asthma - new insights from old clinical trials
Choy, D. F., & Arron, J. R. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1744567 · Cited by 14
Self-citationA critical regulation of Th2 cell responses by RORα in allergic asthma
Lee, J.-E., Choi, G., Cho, M., Kim, D., Lee, M., & Chung, Y. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1825-3 · Cited by 13
An update on the diagnostic biomarkers for asthma
Pandey, R., Parkash, V., Kant, S., Verma, A., Sankhwar, S., Agrawal, A., Parmar, D., Verma, S., & Ahmad, M. K. (2021) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_2037_20 · Cited by 13
“This signature was orthogonal to the type‐2 related inflammation.[135] Though, the two pathways can be associated with the blood T cells.”
BackgroundThe roles of long noncoding RNA-mediated macrophage polarization in respiratory diseases
Qiao, X., Ding, Y., Wu, D., Zhang, A., Yin, Y., Wang, Q., Wang, W. T., & Kang, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1110774 · Cited by 16
Metadata
- Authors
- Choy, D. F., Hart, K. M., Borthwick, L. A., Shikotra, A., Nagarkar, D. R., Siddiqui, S., Jia, G., Ohri, C. M., Doran, E., Vannella, K. M., Butler, C. A., Hargadon, B., Sciurba, J. C., Gieseck, R. L., Thompson, R. W., White, S., Abbas, A. R., Jackman, J., Wu, L. C., Egen, J. G., Heaney, L. G., Ramalingam, T. R., Arron, J. R., Wynn, T. A., & Bradding, P.
- Affiliations
- Genentech (US)
- National Institutes of Health (US)
- Newcastle University (GB)
- University of Leicester (GB)
- Queen's University Belfast (GB)
- Corresponding author
- Choy, David F.
- Hart, Kevin M.
- Arron, Joseph R.
- Wynn, Thomas A.
- Bradding, Peter
- ORCID
- Choy, David F.
- Hart, Kevin M.
- Borthwick, Lee A.
- Nagarkar, Deepti R.
- Siddiqui, Salman
- Jia, Guiquan
- Doran, Emma
- Vannella, Kevin M.
- Butler, Claire A.
- Hargadon, Beverley
- Sciurba, Joshua C.
- Gieseck, Richard L.
- Abbas, Alexander R.
- Jackman, Janet
- Egen, Jackson G.
- Heaney, Liam G.
- Ramalingam, Thirumalai R.
- Arron, Joseph R.
- Wynn, Thomas A.
- Bradding, Peter
- Venue
- Science Translational Medicine
- Published
- 2015-08-19
- Volume
- 7
- Issue
- 301
- Pages
- 301ra129-301ra129
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2166997969
- Cited by
- 450
- References
- 63
- Citations by year
- 2026: 17 · 2025: 25 · 2024: 26 · 2023: 34 · 2022: 41 · 2021: 42 · 2020: 71 · 2019: 46 · 2018: 48 · 2017: 46 · 2016: 48 · 2015: 5
- FWCI
- 36.11
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity) (cc-by-nc)
- Funders
- NIH
- NIAID
- Genentech Inc.
- National Institute for Health Research
- Asthma UK (AUK-PG-2013-208)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- asthma, type 2 inflammation, Th17 inflammation, IL-13, IL-17A, IL-4, asthma endotypes, neutrophilic inflammation, eosinophilia, airway hyperresponsiveness, allergic asthma, combination therapy, cytokine neutralization
- MeSH terms
- Animals, Asthma, Cells, Cultured, Female, Humans, Mice, Inbred BALB C, Signal Transduction, Th2 Cells, Interleukin-13, Interleukin-17, Mice, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.